Rosa Conforti
Centre Hospitalier Universitaire de Nantes(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Hospices Civils de Lyon(FR)Pitié-Salpêtrière Hospital(FR)
Publications by Year
Research Areas
Mycobacterium research and diagnosis, Immune Response and Inflammation, Cancer-related molecular mechanisms research, Immunotherapy and Immune Responses, HER2/EGFR in Cancer Research
Most-Cited Works
- → Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy(2014)1,012 cited
- → TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer(2011)119 cited
- → Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands(2010)103 cited
- → Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials(2007)87 cited
- → The Janus face of dendritic cells in cancer(2008)84 cited
- → How to improve the immunogenicity of chemotherapy and radiotherapy(2011)84 cited